SCHEMBL5086747

SCHEMBL5086747

COCCNC(=O)Cc1ccc(N)c(O)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.67
L3MBTL1 Q9Y468 2/20 0.59
KDM4E B2RXH2 2/20 0.59
GLA P06280 1/20 0.59
IARS1 P41252 2/20 0.50
TRPV1 Q8NER1 1/20 0.49
GAA P10253 2/20 0.48
ALDH1A1 P00352 1/20 0.48
GFER P55789 1/20 0.48
MARS1 P56192 1/20 0.46
CA1 P00915 2/20 0.45
ERCC1 P07992 1/20 0.45
ERCC4 Q92889 1/20 0.45
HDAC4 P56524 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5090335 0.92 CA2 (0.57) CA2L3MBTL1KDM4EGLAIARS1
SCHEMBL5089884 0.84 TRPV1 (0.59) CA2KDM4EIARS1TRPV1GAA
SCHEMBL5094905 0.84 CA2 (0.48) CA2L3MBTL1KDM4EGLAIARS1
SCHEMBL5095795 0.82 TRPV1 (0.50) CA2KDM4EIARS1TRPV1GAA
SCHEMBL5086765 0.82 TRPV1 (0.50) CA2KDM4EIARS1TRPV1GAA
Phosphoric Acid SCHEMBL5434016 0.82 TRPV1 (0.54) CA2KDM4EIARS1TRPV1GAA
SCHEMBL5088894 0.82 TRPV1 (0.68) CA2L3MBTL1KDM4EIARS1TRPV1
SCHEMBL5088853 0.81 TRPV1 (0.51) CA2KDM4EIARS1TRPV1GAA
SCHEMBL5089854 0.80 TRPV1 (0.55) CA2KDM4ETRPV1GAACA1
SCHEMBL5094903 0.80 TRPV1 (0.55) CA2KDM4ETRPV1GAACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2008510738-A 2008-04-10 JP claimed
EP-1781597-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS Wella Aktiengesellschaft (DE) 2007-05-09 EP claimed
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds THE PROCTER & GAMBLE COMPANY (US) 2007-05-03 US claimed
WO-2006021256-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2006-03-02 WO claimed
EP-1781597-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS Wella Aktiengesellschaft (DE) 2007-05-09 EP disclosed
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds THE PROCTER & GAMBLE COMPANY (US) 2007-05-03 US disclosed
WO-2006021256-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds KRT18, TYR, ALPG CA2 1981/4885L3MBTL1 4401/4885KDM4E 586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.